Skip to content

AI-Powered Forecasts for Biotech Investors

Home
Tools
About
Join ScanScor
Log In
- Panel

ScanScor

The AI Biotech Breakout Prediction Strategy

ScanScor

The AI Biotech Breakout Prediction Strategy

Predictions
Scores
News Stream

MSA

AI Biomed Predictions

ATHE – Alterity Therapeutics: Nearing Phase 3 Kickoff, Stock Set to Rise

ScanScor Admin / March 30, 2026

Search

Tools

Predictions
Scores
News Stream

Recent Comments

Recent Comments

1 day ago MEIP – MEI Pharma Poised fo... – LITS (formerly MEIP) is not a viable biotech candidate f... by ScanScor Admin
1 day ago DRRX – Durect Set to Transf... – DURECT was acquired by Bausch Health, the merger closed b... by ScanScor Admin
5 days ago WVE – Wave Life Sciences: P... – WVE would have been wise to hire someone like myself to w... by ScanScor Admin
5 days ago WVE – Wave Life Sciences: P... – The biggest problem may not have been NDAPR at all. It ma... by ScanScor Admin
5 days ago WVE – Wave Life Sciences: P... – The thesis was general, centered on the obesity readout a... by ScanScor Admin

Recent Posts

BCTX – BriaCell Set for Breakout with Key Phase 3 Data Imminent
ATHE – Alterity Therapeutics: Nearing Phase 3 Kickoff, Stock Set to Rise
CTXR – Citius Pharmaceuticals Poised for Growth with LYMPHIR and Pipeline Advances
ALGS – Potential Breakthrough for Aligos Therapeutics in Hepatitis B Treatment
BFRI – Biofrontera Nears Potential Breakthrough with FDA Decision

ScanScor empowers traders and investors with instant
AI-driven access to trusted intelligence.

🧠 Powered by real-time AI
🔍 Trained to find the moment before it moves

Terms and Conditions
About
Join the ScanScor Revolution

Disclaimer: ScanScor provides research and educational information only. Nothing on this site is financial advice or a recommendation to buy or sell securities. ScanScor does not provide forecasts or guarantee any outcomes. Past performance is not indicative of future results.

Copyright © 2026 ScanScor

Best viewed on desktop. Mobile optimization coming soon.

Scroll to Top